Non - invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin /
Ahmed Mohamed Ismail
Non - invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin / دلالات التليف اللاتداخليه فى الدم والفايبروسكان فى مواجهة العينه الكبديه كمتنبأت لنتيجة علاج فيروس سى الكبدى بعقار الأنترفيرون طويل المفعول والريبافيرين Ahmed Mohamed Ismail ; Supervised Ayman Yossry Abdelrehim , Rabab Fouad Emam , Ehsan Hassan Hassan - Cairo : Ahmed Mohamed Ismail , 2013 - 130 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Hepatitis C virus (HCV) accounts for a sizable proportion of cases of chronic liver disease, liver disease deaths and cases of hepatocellular carcinoma and represents the most common indication for liver transplantation (LTx). Projections based on the current prevalence of infection and anticipated rates of progression suggest that the morbidity and mortality as well as the medical care costs attributable to HCV infection will escalate alarmingly during the next two decades
Chronic HCV Interferon Ribavirin
Non - invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin / دلالات التليف اللاتداخليه فى الدم والفايبروسكان فى مواجهة العينه الكبديه كمتنبأت لنتيجة علاج فيروس سى الكبدى بعقار الأنترفيرون طويل المفعول والريبافيرين Ahmed Mohamed Ismail ; Supervised Ayman Yossry Abdelrehim , Rabab Fouad Emam , Ehsan Hassan Hassan - Cairo : Ahmed Mohamed Ismail , 2013 - 130 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Hepatitis C virus (HCV) accounts for a sizable proportion of cases of chronic liver disease, liver disease deaths and cases of hepatocellular carcinoma and represents the most common indication for liver transplantation (LTx). Projections based on the current prevalence of infection and anticipated rates of progression suggest that the morbidity and mortality as well as the medical care costs attributable to HCV infection will escalate alarmingly during the next two decades
Chronic HCV Interferon Ribavirin